Navigation Links
NYCEDC Announces Winners of Innovate Health Tech, Highlighting Innovation in NYC's Healthcare Sector
Date:7/23/2013

NEW YORK, July 23, 2013 /PRNewswire/ -- New York City Economic Development Corporation (NYCEDC) today announced the winners of Innovate Health Tech NYC, a competition designed to promote innovation within New York City's health technology sector.  Innovate Health Tech NYC, an initiative of NYCEDC sponsored by Janssen Healthcare Innovation (JHI), recognizes early-stage health technology companies and entrepreneurs tackling pressing issues affecting human health. On Wednesday, July 10th, ten finalists met at WeWork Lounge in NYC to pitch their pre-commercial, prototype stage technologies to a panel of expert judges and 150 members of the healthcare and tech communities. Three of these companies received Third, Second and Grand Prizes worth $50,000 in total.

The winning companies were:

  • Grand Prize ($25,000): Kinsa works at the intersection of technology, design, and healthcare to create the world's first real-time map of human health. The company's first product is a smartphone-connected thermometer. The Kinsa Smart Thermometer helps users track their illness history, share that with physicians, manage and plan around their illness, and view the "health weather" in their local area.
  • 2nd Place ($15,000): Oculogica has discovered the Rosetta Stone to decipher what the brain is saying through the language of eye movements. This discovery has led the company to develop a low-cost, software-based diagnostic that will provide a safe, non-invasive and mobile test to diagnose the extent of concussion and a broad spectrum of other diseases' states. Oculogica's test will significantly improve patient care by providing better information than the current standard of care, which is more costly and invasive.
  • 3rd Place ($10,000): AdhereTech has created patented wireless pill bottles that improve medication adherence. Many patients fail to take their medication properly, increasing U.S. healthcare costs by $300 billion annually. AdhereTech's bottles measure the exact number of pills in the bottle in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via automated phone call or text message.

"Health 2.0 is thrilled with the success of both the Innovate Health Tech NYC competition and the Demo Day!" said Jean-Luc Neptune, SVP at Health 2.0, NYCEDC's administrative partner. "We look forward to continuing to support the New York City health tech community with further collaborations with NYCEDC, Janssen Healthcare Innovation, and fellow partners StartUp Health and ChallengePost."

Innovate Health Tech NYC was developed out of Eds & Meds NYC 2020, a strategic review of the life sciences and healthcare sectors in NYC. NYCEDC held extensive conversations with senior academic stakeholders, investors and entrepreneurs in NYC and beyond.

New York City is home to an increasingly robust healthcare sector, which includes world-class academic medical centers, top pharmaceutical companies, as well as numerous physician practices, nursing associations and clinics. Most recently, NYCEDC announced a partnership that will lead to the creation of Harlem Biospace, a life sciences incubator that will provide affordable wet-lab and microbench facilities, specialized laboratory equipment, mentorship and business support to early-stage life sciences companies.  Harlem Biospace is designed to help create a thriving biotech community for turning revolutionary ideas into products that will solve important health problems.

Janssen Healthcare Innovation (JHI) is an entrepreneurial team within Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. JHI collaborates with entrepreneurs to create integrated care businesses and enabling technologies that will transform the consumer healthcare experience, improve outcomes and reduce healthcare costs.

Media contact:
Sophie Park
760-604-3563
sophie@health2con.com


'/>"/>
SOURCE New York City Economic Development Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
2. NSG Precision Cells Announces the Release of High Quality Calibration Standards for UV-VIS Spectrophotometers
3. Techne Corporation Announces Acquisition Completion
4. Life Technologies Announces Filing of Definitive Proxy Statement
5. RXi Pharmaceuticals Announces Application for NASDAQ Capital Market Listing and Reverse Stock Split
6. ComplianceOnline Announces Seminar on Latin American Regulatory Requirements for Life Sciences Products
7. Saladax Biomedical Announces Addition to Leadership Team
8. Signal Genetics LLC Announces Update to MyPRS™ Gene Expression Profiling Assay for Multiple Myeloma
9. SPIE Announces 2013 Scholarship Recipients
10. Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
11. Centrillion Biosciences Announces Winners of Next-gen Sequencing Innovation Grant Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global ... ... CAGR of 16.83% during the period 2017-2021. The report ... market for 2017-2021. To calculate the market size, the report considers the ... also includes a a discussion of the key vendors operating in this ...
(Date:1/12/2017)... (PRWEB) , ... January 12, ... ... USING VTI’S INTERFUSE® IS A SUCCESS , VTI, Vertebral Technologies, Inc., announces ... the InterFuse® laterally expandable device. Since September 2016, VTI (Vertebral Technologies, Inc.) ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months to live. ... drug combination that has stabilized Rosendahl’s disease and increased both the quantity and ...
(Date:1/12/2017)... -- The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), ... - Global Forecast to 2022", published by MarketsandMarkets, the global market is estimated ... USD 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition ... Service, Application Area, End User, And Region - Global Forecast to 2021", published ... in 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):